Clinical trial
Comparison of the Efficacy of a 7-day Versus 14-day Course of Intravenous Antibiotics in the Treatment of Uncomplicated Neonatal Bacterial Sepsis: a Randomized Controlled Non-inferiority Trial
NCT03280147 is registered in ClinicalTrials.gov with Indian Council of Medical Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy of a 7-day Versus 14-day Course of Intravenous Antibiotics in the Treatment of Uncomplicated Neonatal Bacterial Sepsis: a Randomized Controlled Non-inferiority Trial
- Lead sponsor
- Indian Council of Medical Research
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 1, 2019
- Completion date
- January 31, 2023
- Enrollment
- 261 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
anti-bacterial agents, infant, newborn, neonatal sepsis, recurrence